Understand nacre
Biomineralisation, architecture and biological interactions underpin our work.
Explore the science
FRContact MEGA BIOPHARMA · Medical biomaterials
We develop nacre-derived biomaterials for bone and tissue regeneration. Our first programme, Bionacre® Bone Graft, targets dental surgery.
Late preclinical stage · Preparing the regulatory pathway

Why nacre?
Nacre combines a mineral structure with an organic matrix. Our research explores their interactions with living tissues to develop new approaches to bone repair.
Biomineralisation, architecture and biological interactions underpin our work.
Explore the scienceProprietary processes to prepare, characterise and shape nacre.
Explore the platformNacre-based granules being developed for filling dental bone defects.
Explore the programme
Our first programme
Bone regeneration in dental surgery is our first application. The programme is in late preclinical development.
Next steps: complete the assessments and prepare regulatory submissions, with a planned US FDA 510(k) pathway.
Request the roadmapBionacre® Bone Graft has not received FDA clearance for marketing in the United States.
One team, one ambition
“Our ambition is to turn nacre’s potential into medical biomaterials. With Bionacre®, we bring together research, industrial expertise and regulatory development around a first programme: bone regeneration.”
Joël Drai · Founder & Chairman




Research & manufacturing in France
In Crosne, our teams connect research, nacre processing and quality control. A network of experts supports our biomaterials development.